Ms. Angela Griffiths, LPN Licensed Vocational Nurse Medicare: Not Enrolled in Medicare Practice Location: 32946 Woodbine Rd, Leesburg, FL 34748 Phone: 352-246-5900 |
News Archive
Today's announcement that the U.S. Food and Drug Administration has approved ProvengeĆ¢, a new form of therapy for some prostate cancer patients, marks the beginning of an era in which patients' own immune systems become part of the standard therapeutic arsenal against cancer, say Dana-Farber Cancer Institute investigators who led a study of the treatment's effectiveness in patients.
A new free resource allows researchers to use Medicare and other payer claims databases to identify and meaningfully characterize medical imaging by noninvasive or invasive procedures, modality, body region and clinical focus. Developed by the Harvey L. Neiman Health Policy Institute, the Neiman Imaging Types of Service (NITOS) coding platform is an open source classification system, allowing users to readily extract utilization and cost data to examine the role and value of medical imaging.
Pulmonary function test results (PFTs) in patients treated with AFREZZATM (insulin human [rDNA origin]) Inhalation Powder, a well-tolerated, ultra rapid acting insulin, at follow-up measurements were similar to PFT results observed in patients receiving standard antidiabetic therapy, according to data presented today at the American Association of Clinical Endocrinologists 19th Annual Meeting (Poster #267).
A chemical in the brain typically associated with cognition, movement and reward-motivation behavior - among others - may also play a role in promoting chronic pain, according to new research at The University of Texas at Dallas.
Two genes work together to drive the most lethal forms of prostate cancer, according to new research from the Herbert Irving Comprehensive Cancer Center at Columbia University Medical Center (CUMC).
› Verified 9 days ago